ウエスタンブロッティング市場

出版:MarketsandMarkets(マーケッツアンドマーケッツ) 出版年月:2021年11月

ウエスタンブロッティング市場: 製品[消耗品(抗体)、機器(電気泳動、ブロッティングシステム、イメージャー(蛍光))]、用途(生物医学、臨床診断)、エンドユーザー(研究所、病院、バイオファーマ)- 2026年までの世界予測

Western Blotting Market by Product, (Consumables (Antibody), Instrument (Electrophoresis, Blotting System, Imager (Fluorescent))), Application (Biomedical, Clinical Diagnostics), End User (Research Institute, Hospital, Biopharma) – Global Forecast to 2026

ページ数 263
図表数 350
種別 英文調査報告書

目次  お問合せ

The global western blotting market is projected to reach USD 1.4 billion by 2026 from USD 1.0 billion in 2021, at a CAGR of 6.7% during the forecast period. Technological advancements, increasing government funding in the field of biomedical research, growing demand for personalized medicine, and the rising prevalence of HIV are the key factors driving the market growth.

“By instruments segment, the imagers sub segment accounted for the fastest-growing segment of the western blotting market”
Based on instruments, the western blotting market is segmented into gel electrophoresis instruments, blotting systems, and imagers. Growth in this product segment is primarily due to the automation of imagers, which simplifies the protein detection process.

“By end user segment, the academic & research institutes segment accounted for the largest share of the western blotting market”
Based on end users, the western blotting market is segmented into academic & research institutes, biopharmaceutical & biotechnology companies, hospitals & diagnostic laboratories, and other end users In 2020, academic & research institutes accounted for the largest share of the western blotting market. The large share of the academic & research institutes end-user segment can be attributed to growing government investments for research activities and increasing research in the area of proteomics.

“Asia Pacific: The fastest-growing region in the western blotting market.”
The western blotting market in the Asia Pacific region is projected to register the highest growth during the forecast period. The major factors driving the growth of the Asia Pacific market include strong government support for the growth of the pharmaceutical and biotechnology industry, the presence of bioclusters in China and India, increasing funding for life science research, and growing initiatives related to target disease diagnosis.

“North America: the largest share of the western blotting market”
In 2020, North America accounted for the largest share of the western blotting market. The major factors driving the growth of this regional market include the presence of top manufacturers of western blotting products in this region, rise in research funding, increasing investments in proteomics research, and growing focus on personalized medicine.

Breakdown of primaries

The study contains insights from various industry experts, ranging from component suppliers to Tier 1 companies and OEMs. The break-up of the primaries is as follows:

• By Respondent– Supply Side- 70%, Demand Side-30%
• By Designation— CXOs and Directors- 30%, Executives – 25%, Mangers – 45%
• By Region— North America – 40%, Europe – 25%, APAC – 20%, LATAM- 10% , MEA- 5%

Prominent players in the western blotting market include Bio-Rad Laboratories, Inc. (US), Thermo Fisher Scientific Inc. (US), Danaher Corporation (US), Merck KGaA (Germany), Bio-Techne Corporation (US), PerkinElmer, Inc. (US), LI-COR, Inc. (US), Advansta Inc. (US), Cell Signaling Technology, Inc. (US), F. Hoffmann-La Roche Ltd. (Switzerland), Azure Biosystems, Inc. (US), Boster Biological Technology (US), Geno Technology Inc. (US), Rockland Immunochemicals, Inc. (US), Precision Biosystems (US), Cleaver Scientific Ltd. (UK), Abcam Plc (UK), Proteintech Group (US), Enzo Biochem, Inc. (US), Abnova Corporation (Taiwan), Sino Biological Inc. (China), StressMarq Biosciences Inc. (Canada), Abbexa Ltd. (UK), Covalab S.A.S. (France), and Biorbyt Ltd. (UK).

Research Coverage:
The report segments the western blotting market based on region (the Asia Pacific, Europe, North America, Latin America, and the Middle East & Africa), product (consumables [Reagents & Buffers, Antibodies & Conjugates {Primary Antibodies, Secondary Antibodies, Other Antibodies & Conjugates}, Kits
Membranes & Filter Papers Other Consumables], instruments [Electrophoresis, Blotting Systems {Semi-dry Blotting Systems, Wet Blotting Systems}, Imagers {Chemiluminescent Imagers, Fluorescent Imagers, Other Imagers}]), application (Biomedical Research, Clinical Diagnostics [HIV, Lyme Disease, Hepatitis, Other Diseases], Agricultural Applications, Other Applications), and end-user (Academic & Research Institutes, Biopharmaceutical & Biotechnology Companies, Hospitals & Diagnostic Laboratories, Other End Users). The report also provides a comprehensive review of market drivers, restraints opportunities, challenges and trends in the western blotting market.

Key Benefits of Buying the Report:

The report will help the leaders/new entrants in this market with information on the closest approximations of the revenue numbers for the overall market and the sub-segments. This report will help stakeholders understand the competitive landscape and gain more insights to better position their businesses and plan suitable go-to-market strategies. The report also helps stakeholders understand the pulse of the western blotting market and provides them information on key market drivers, restraints, challenges, and opportunities.


目次

1 INTRODUCTION 41
1.1 OBJECTIVES OF THE STUDY 41
1.2 MARKET DEFINITION 42
1.2.1 INCLUSIONS & EXCLUSIONS 42
1.3 MARKET SCOPE 43
1.3.1 MARKETS COVERED 43
FIGURE 1 WESTERN BLOTTING MARKET SEGMENTATION 43
1.3.2 YEARS CONSIDERED FOR THE STUDY 43
1.4 CURRENCY 44
1.5 LIMITATIONS 44
1.6 STAKEHOLDERS 44
1.7 SUMMARY OF CHANGES 45
2 RESEARCH METHODOLOGY 46
2.1 RESEARCH DATA 46
FIGURE 2 RESEARCH DESIGN 46
2.1.1 SECONDARY DATA 46
2.1.2 PRIMARY DATA 47
FIGURE 3 PRIMARY SOURCES 48
FIGURE 4 WESTERN BLOTTING MARKET: BREAKDOWN OF PRIMARIES 48
2.1.2.1 Key industry insights 49
2.2 MARKET SIZE ESTIMATION 50
FIGURE 5 MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS, 2020 50
FIGURE 6 MARKET SIZE ESTIMATION METHODOLOGY: BOTTOM-UP (SUPPLY SIDE) – COLLECTIVE REVENUE OF ALL WESTERN BLOTTING PRODUCTS 50
FIGURE 7 WESTERN BLOTTING MARKET: CAGR PROJECTIONS, 2021–2026 52
FIGURE 8 WESTERN BLOTTING MARKET: GROWTH ANALYSIS OF DRIVERS, RESTRAINTS OPPORTUNITIES, AND CHALLENGES 52
2.3 MARKET BREAKDOWN AND DATA TRIANGULATION 54
FIGURE 9 DATA TRIANGULATION METHODOLOGY 54
2.4 RESEARCH LIMITATIONS 55
2.5 GROWTH RATE ASSUMPTIONS 55
2.6 RISK ANALYSIS 56
3 EXECUTIVE SUMMARY 57
FIGURE 10 WESTERN BLOTTING MARKET, BY PRODUCT, 2021 VS. 2026 (USD MILLION) 57
FIGURE 11 WESTERN BLOTTING MARKET, BY APPLICATION,
2021 VS. 2026 (USD MILLION) 58
FIGURE 12 WESTERN BLOTTING MARKET SHARE, BY END USER, 2020 58
FIGURE 13 GEOGRAPHICAL SNAPSHOT OF THE WESTERN BLOTTING MARKET 59
4 PREMIUM INSIGHTS 60
4.1 WESTERN BLOTTING MARKET OVERVIEW 60
FIGURE 14 TECHNOLOGICAL ADVANCEMENTS AND GROWING DEMAND FOR PERSONALIZED MEDICINE ARE KEY FACTORS DRIVING GROWTH IN
THE WESTERN BLOTTING MARKET 60
4.2 ASIA PACIFIC: WESTERN BLOTTING MARKET, BY END USER & COUNTRY (2020) 61
FIGURE 15 ACADEMIC & RESEARCH INSTITUTES ACCOUNTED FOR THE LARGEST SHARE OF THE ASIA PACIFIC MARKET IN 2020 61
4.3 WESTERN BLOTTING INSTRUMENTS MARKET, BY TYPE, 2020 61
FIGURE 16 THE BLOTTING SYSTEMS SEGMENT DOMINATED THE MARKET IN 2020 61
4.4 WESTERN BLOTTING INSTRUMENTS MARKET FOR BLOTTING SYSTEMS, BY TYPE, 2020 62
FIGURE 17 THE SEMI-DRY BLOTTING SYSTEMS SEGMENT IS PROJECTED TO WITNESS
THE HIGHEST GROWTH DURING THE FORECAST PERIOD 62
4.5 WESTERN BLOTTING INSTRUMENTS MARKET FOR IMAGERS, BY TYPE, 2020 62
FIGURE 18 THE CHEMILUMINESCENT IMAGERS SEGMENT ACCOUNTED FOR THE LARGEST SHARE OF THE WESTERN BLOTTING MARKET IN 2020 62
5 MARKET OVERVIEW 63
5.1 INTRODUCTION 63
5.2 MARKET DYNAMICS 63
FIGURE 19 WESTERN BLOTTING MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES,
AND CHALLENGES 63
5.2.1 DRIVERS 64
5.2.1.1 Technological advancements 64
5.2.1.2 Increasing government funding in the field of biomedical research 64
5.2.1.3 Growing demand for personalized medicine 65
FIGURE 20 NUMBER OF PERSONALIZED MEDICINES IN THE MARKET, 2008–2020 65
5.2.1.4 Rising global prevalence and incidence of HIV/AIDS 66
TABLE 1 INCIDENCE OF HIV/AIDS, BY REGION, 2020 66
5.2.2 RESTRAINTS 67
5.2.2.1 Emergence of alternative technologies 67
5.2.3 OPPORTUNITIES 67
5.2.3.1 Emerging economies 67
5.2.4 CHALLENGES 68
5.2.4.1 Requirement of high procedural efficiency for accurate results 68
5.3 IMPACT OF COVID-19 ON THE WESTERN BLOTTING MARKET 69
5.4 PATENT ANALYSIS 70
5.4.1 NUMBER OF PUBLICATIONS OVER THE LAST 10 YEARS 70
5.4.2 TOP 10 GRANTED PATENT OWNERS IN THE LAST 20 YEARS 70
5.4.3 TOP 10 PLAYERS WITH THE HIGHEST NO. OF PATENT APPLICATIONS 71
5.4.4 LIST OF RECENT PATENTS 71
5.5 REGULATORY GUIDELINES 72
5.5.1 NORTH AMERICA 72
5.5.2 EUROPE 72
5.5.3 EMERGING MARKETS 72
5.6 VALUE CHAIN ANALYSIS 73
FIGURE 21 VALUE CHAIN ANALYSIS: MAJOR VALUE ADDED DURING THE MANUFACTURING AND ASSEMBLY PHASES 73
5.7 SUPPLY CHAIN ANALYSIS 74
FIGURE 22 DIRECT DISTRIBUTION—THE PREFERRED STRATEGY FOR PROMINENT COMPANIES 75
5.8 PORTER’S FIVE FORCES ANALYSIS 75
TABLE 2 WESTERN BLOTTING MARKET: PORTER’S FIVE FORCES ANALYSIS 75
5.8.1 DEGREE OF COMPETITION 75
5.8.2 BARGAINING POWER OF SUPPLIERS 76
5.8.3 BARGAINING POWER OF BUYERS 76
5.8.4 THREAT FROM SUBSTITUTES 76
5.8.5 THREAT FROM NEW ENTRANTS 76
5.9 ECOSYSTEM ANALYSIS OF THE WESTERN BLOTTING MARKET 77
FIGURE 23 ECOSYSTEM ANALYSIS OF THE WESTERN BLOTTING MARKET 77
5.9.1 ROLE IN THE ECOSYSTEM 77
5.10 TECHNOLOGY ANALYSIS 78
5.10.1 ALTERNATIVES TO TRADITIONAL WESTERN BLOTTING 78
5.11 RANGES/SCENARIOS 79
FIGURE 24 DEPENDING ON HOW THE UNCERTAINTIES UNFOLD, WE SEE A SPECTRUM OF SCENARIOS FOR THE WESTERN BLOTTING MARKET 79
5.12 TRADE ANALYSIS 80
5.12.1 TRADE ANALYSIS FOR WESTERN BLOTTING 80
TABLE 3 IMPORT DATA FOR HS CODE 90278090, BY COUNTRY,
2016–2020 (USD MILLION) 80
TABLE 4 EXPORT DATA FOR HS CODE 90278090, BY COUNTRY,
2016–2020 (USD MILLION) 80
5.13 TRENDS/DISRUPTIONS IMPACTING CUSTOMER’S BUSINESS 81
6 WESTERN BLOTTING MARKET, BY PRODUCT 82
6.1 INTRODUCTION 83
TABLE 5 WESTERN BLOTTING MARKET, BY PRODUCT, 2019–2026 (USD MILLION) 83
6.2 CONSUMABLES 83
TABLE 6 WESTERN BLOTTING CONSUMABLES MARKET, BY TYPE,
2019–2026 (USD MILLION) 83
TABLE 7 WESTERN BLOTTING CONSUMABLES MARKET, BY REGION,
2019–2026 (USD MILLION) 84
TABLE 8 NORTH AMERICA: WESTERN BLOTTING CONSUMABLES MARKET,
BY COUNTRY, 2019–2026 (USD MILLION) 84
TABLE 9 EUROPE: WESTERN BLOTTING CONSUMABLES MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 84
TABLE 10 APAC: WESTERN BLOTTING CONSUMABLES MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 85
6.2.1 REAGENTS & BUFFERS 85
6.2.1.1 High consumption of reagents & buffers during the western blot process to drive market growth 85
TABLE 11 WESTERN BLOTTING MARKET FOR REAGENTS & BUFFERS, BY REGION, 2019–2026 (USD MILLION) 86
TABLE 12 NORTH AMERICA: WESTERN BLOTTING MARKET FOR REAGENTS & BUFFERS, BY COUNTRY, 2019–2026 (USD MILLION) 86
TABLE 13 EUROPE: WESTERN BLOTTING MARKET FOR REAGENTS & BUFFERS,
BY COUNTRY, 2019–2026 (USD MILLION) 87
TABLE 14 APAC: WESTERN BLOTTING MARKET FOR REAGENTS & BUFFERS,
BY COUNTRY, 2019–2026 (USD MILLION) 87
6.2.2 ANTIBODIES & CONJUGATES 87
TABLE 15 WESTERN BLOTTING MARKET FOR ANTIBODIES & CONJUGATES, BY TYPE, 2019–2026 (USD MILLION) 87
TABLE 16 WESTERN BLOTTING MARKET FOR ANTIBODIES & CONJUGATES, BY REGION, 2019–2026 (USD MILLION) 88
TABLE 17 NORTH AMERICA: WESTERN BLOTTING MARKET FOR ANTIBODIES & CONJUGATES, BY COUNTRY, 2019–2026 (USD MILLION) 88
TABLE 18 EUROPE: WESTERN BLOTTING MARKET FOR ANTIBODIES & CONJUGATES,
BY COUNTRY, 2019–2026 (USD MILLION) 88
TABLE 19 APAC: WESTERN BLOTTING MARKET FOR ANTIBODIES & CONJUGATES,
BY COUNTRY, 2019–2026 (USD MILLION) 89
6.2.2.1 Primary antibodies 89
6.2.2.1.1 Primary antibodies are mainly used to recognize a specific protein of interest 89
TABLE 20 WESTERN BLOTTING MARKET FOR PRIMARY ANTIBODIES, BY REGION,
2019–2026 (USD MILLION) 89
TABLE 21 NORTH AMERICA: WESTERN BLOTTING MARKET FOR PRIMARY ANTIBODIES, BY COUNTRY, 2019–2026 (USD MILLION) 90
TABLE 22 EUROPE: WESTERN BLOTTING MARKET FOR PRIMARY ANTIBODIES,
BY COUNTRY, 2019–2026 (USD MILLION) 90
TABLE 23 APAC: WESTERN BLOTTING MARKET FOR PRIMARY ANTIBODIES,
BY COUNTRY, 2019–2026 (USD MILLION) 90
6.2.2.2 Secondary antibodies 91
6.2.2.2.1 High sensitivity of secondary antibodies makes it easier to detect proteins of interest in complex protein mixtures 91
TABLE 24 WESTERN BLOTTING MARKET FOR SECONDARY ANTIBODIES, BY REGION, 2019–2026 (USD MILLION) 91
TABLE 25 NORTH AMERICA: WESTERN BLOTTING MARKET FOR SECONDARY ANTIBODIES, BY COUNTRY, 2019–2026 (USD MILLION) 91
TABLE 26 EUROPE: WESTERN BLOTTING MARKET FOR SECONDARY ANTIBODIES,
BY COUNTRY, 2019–2026 (USD MILLION) 92
TABLE 27 APAC: WESTERN BLOTTING MARKET FOR SECONDARY ANTIBODIES,
BY COUNTRY, 2019–2026 (USD MILLION) 92
6.2.2.3 Other antibodies & conjugates 92
TABLE 28 WESTERN BLOTTING MARKET FOR OTHER ANTIBODIES & CONJUGATES,
BY REGION, 2019–2026 (USD MILLION) 93
TABLE 29 NORTH AMERICA: WESTERN BLOTTING MARKET FOR OTHER ANTIBODIES & CONJUGATES, BY COUNTRY, 2019–2026 (USD MILLION) 93
TABLE 30 EUROPE: WESTERN BLOTTING MARKET FOR OTHER ANTIBODIES & CONJUGATES, BY COUNTRY, 2019–2026 (USD MILLION) 93
TABLE 31 APAC: WESTERN BLOTTING MARKET FOR OTHER ANTIBODIES & CONJUGATES, BY COUNTRY, 2019–2026 (USD MILLION) 94
6.2.3 KITS 94
6.2.3.1 Repeat purchases of single-use ready-to-use kits to drive market growth 94
TABLE 32 WESTERN BLOTTING MARKET FOR KITS, BY REGION,
2019–2026 (USD MILLION) 94
TABLE 33 NORTH AMERICA: WESTERN BLOTTING MARKET FOR KITS, BY COUNTRY, 2019–2026 (USD MILLION) 95
TABLE 34 EUROPE: WESTERN BLOTTING MARKET FOR KITS, BY COUNTRY,
2019–2026 (USD MILLION) 95
TABLE 35 APAC: WESTERN BLOTTING MARKET FOR KITS, BY COUNTRY,
2019–2026 (USD MILLION) 95
6.2.4 MEMBRANES & FILTER PAPERS 96
6.2.4.1 Extensive usage of membranes & filter papers to support the immobilization and transfer steps during western blotting experiments to drive market growth 96
TABLE 36 COMPARISON OF NITROCELLULOSE MEMBRANES AND PVDF MEMBRANES 96
TABLE 37 WESTERN BLOTTING MARKET FOR MEMBRANES & FILTER PAPERS,
BY REGION, 2019–2026 (USD MILLION) 97
TABLE 38 NORTH AMERICA: WESTERN BLOTTING MARKET FOR MEMBRANES & FILTER PAPERS, BY COUNTRY, 2019–2026 (USD MILLION) 97
TABLE 39 EUROPE: WESTERN BLOTTING MARKET FOR MEMBRANES & FILTER PAPERS, BY COUNTRY, 2019–2026 (USD MILLION) 97
TABLE 40 APAC: WESTERN BLOTTING MARKET FOR MEMBRANES & FILTER PAPERS,
BY COUNTRY, 2019–2026 (USD MILLION) 98
6.2.5 OTHER CONSUMABLES 98
TABLE 41 WESTERN BLOTTING MARKET FOR OTHER CONSUMABLES, BY REGION, 2019–2026 (USD MILLION) 98
TABLE 42 NORTH AMERICA: WESTERN BLOTTING MARKET FOR OTHER CONSUMABLES, BY COUNTRY, 2019–2026 (USD MILLION) 99
TABLE 43 EUROPE: WESTERN BLOTTING MARKET FOR OTHER CONSUMABLES,
BY COUNTRY, 2019–2026 (USD MILLION) 99
TABLE 44 APAC: WESTERN BLOTTING MARKET FOR OTHER CONSUMABLES,
BY COUNTRY, 2019–2026 (USD MILLION) 99
6.3 INSTRUMENTS 100
TABLE 45 WESTERN BLOTTING INSTRUMENTS MARKET, BY REGION,
2019–2026 (USD MILLION) 100
TABLE 46 NORTH AMERICA: WESTERN BLOTTING INSTRUMENTS MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 100
TABLE 47 EUROPE: WESTERN BLOTTING INSTRUMENTS MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 101
TABLE 48 APAC: WESTERN BLOTTING INSTRUMENTS MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 101
TABLE 49 WESTERN BLOTTING INSTRUMENTS MARKET, BY TYPE,
2019–2026 (USD MILLION) 101

6.3.1 GEL ELECTROPHORESIS INSTRUMENTS 102
6.3.1.1 Increased demand for 2D electrophoresis due to its high separation performance is one of the major factors driving the growth of
the market 102
TABLE 50 WESTERN BLOTTING MARKET FOR GEL ELECTROPHORESIS INSTRUMENTS, BY REGION, 2019–2026 (USD MILLION) 102
TABLE 51 NORTH AMERICA: WESTERN BLOTTING MARKET FOR GEL ELECTROPHORESIS INSTRUMENTS, BY COUNTRY, 2019–2026 (USD MILLION) 103
TABLE 52 EUROPE: WESTERN BLOTTING MARKET FOR GEL ELECTROPHORESIS INSTRUMENTS, BY COUNTRY, 2019–2026 (USD MILLION) 103
TABLE 53 APAC: WESTERN BLOTTING MARKET FOR GEL ELECTROPHORESIS INSTRUMENTS, BY COUNTRY, 2019–2026 (USD MILLION) 103
6.3.2 BLOTTING SYSTEMS 104
TABLE 54 COMPARISON BETWEEN PROTEIN BLOTTING SYSTEMS 104
TABLE 55 WESTERN BLOTTING MARKET FOR BLOTTING SYSTEMS, BY TYPE,
2019–2026 (USD MILLION) 104
TABLE 56 WESTERN BLOTTING MARKET FOR BLOTTING SYSTEMS, BY REGION,
2019–2026 (USD MILLION) 105
TABLE 57 NORTH AMERICA: WESTERN BLOTTING MARKET FOR BLOTTING SYSTEMS,
BY COUNTRY, 2019–2026 (USD MILLION) 105
TABLE 58 EUROPE: WESTERN BLOTTING MARKET FOR BLOTTING SYSTEMS,
BY COUNTRY, 2019–2026 (USD MILLION) 105
TABLE 59 APAC: WESTERN BLOTTING MARKET FOR BLOTTING SYSTEMS, BY COUNTRY, 2019–2026 (USD MILLION) 106
6.3.2.1 Wet blotting systems 106
6.3.2.1.1 Wet systems are most commonly used for the transfer of proteins from gels to membranes 106
TABLE 60 WESTERN BLOTTING MARKET FOR WET BLOTTING SYSTEMS, BY REGION, 2019–2026 (USD MILLION) 106
TABLE 61 NORTH AMERICA: WESTERN BLOTTING MARKET FOR WET BLOTTING SYSTEMS, BY COUNTRY, 2019–2026 (USD MILLION) 107
TABLE 62 EUROPE: WESTERN BLOTTING MARKET FOR WET BLOTTING SYSTEMS,
BY COUNTRY, 2019–2026 (USD MILLION) 107
TABLE 63 APAC: WESTERN BLOTTING MARKET FOR WET BLOTTING SYSTEMS,
BY COUNTRY, 2019–2026 (USD MILLION) 107
6.3.2.2 Semi-dry blotting systems 108
6.3.2.2.1 Minimal usage of buffers during the process and rapid transfer of proteins from gels to membranes are major factors driving the demand for semi-dry blotting systems 108
TABLE 64 WESTERN BLOTTING MARKET FOR SEMI-DRY BLOTTING SYSTEMS, BY REGION, 2019–2026 (USD MILLION) 108
TABLE 65 NORTH AMERICA: WESTERN BLOTTING MARKET FOR SEMI-DRY BLOTTING SYSTEMS, BY COUNTRY, 2019–2026 (USD MILLION) 108
TABLE 66 EUROPE: WESTERN BLOTTING MARKET FOR SEMI-DRY BLOTTING SYSTEMS, BY COUNTRY, 2019–2026 (USD MILLION) 109
TABLE 67 APAC: WESTERN BLOTTING MARKET FOR SEMI-DRY BLOTTING SYSTEMS,
BY COUNTRY, 2019–2026 (USD MILLION) 109

6.3.3 IMAGERS 109
TABLE 68 WESTERN BLOTTING MARKET FOR IMAGERS, BY TYPE,
2019–2026 (USD MILLION) 110
TABLE 69 WESTERN BLOTTING MARKET FOR IMAGERS, BY REGION,
2019–2026 (USD MILLION) 110
TABLE 70 NORTH AMERICA: WESTERN BLOTTING MARKET FOR IMAGERS, BY COUNTRY, 2019–2026 (USD MILLION) 110
TABLE 71 EUROPE: WESTERN BLOTTING MARKET FOR IMAGERS, BY COUNTRY,
2019–2026 (USD MILLION) 111
TABLE 72 APAC: WESTERN BLOTTING MARKET FOR IMAGERS, BY COUNTRY,
2019–2026 (USD MILLION) 111
6.3.3.1 Chemiluminescent imagers 111
6.3.3.1.1 Low cost of these imagers, easy handling, and sensitivity are some of the key factors contributing to the large share of this market 111
TABLE 73 WESTERN BLOTTING MARKET FOR CHEMILUMINESCENT IMAGERS,
BY REGION, 2019–2026 (USD MILLION) 112
TABLE 74 NORTH AMERICA: WESTERN BLOTTING MARKET FOR CHEMILUMINESCENT IMAGERS, BY COUNTRY, 2019–2026 (USD MILLION) 112
TABLE 75 EUROPE: WESTERN BLOTTING MARKET FOR CHEMILUMINESCENT IMAGERS, BY COUNTRY, 2019–2026 (USD MILLION) 112
TABLE 76 APAC: WESTERN BLOTTING MARKET FOR CHEMILUMINESCENT IMAGERS,
BY COUNTRY, 2019–2026 (USD MILLION) 113
6.3.3.2 Fluorescent imagers 113
6.3.3.2.1 Fluorescent imagers serve as one-stop imaging systems as they avoid multiple film exposures and development steps 113
TABLE 77 WESTERN BLOTTING MARKET FOR FLUORESCENT IMAGERS, BY REGION, 2019–2026 (USD MILLION) 113
TABLE 78 NORTH AMERICA: WESTERN BLOTTING MARKET FOR FLUORESCENT IMAGERS, BY COUNTRY, 2019–2026 (USD MILLION) 114
TABLE 79 EUROPE: WESTERN BLOTTING MARKET FOR FLUORESCENT IMAGERS,
BY COUNTRY, 2019–2026 (USD MILLION) 114
TABLE 80 APAC: WESTERN BLOTTING MARKET FOR FLUORESCENT IMAGERS,
BY COUNTRY, 2019–2026 (USD MILLION) 114
6.3.3.3 Other imagers 115
TABLE 81 WESTERN BLOTTING MARKET FOR OTHER IMAGERS, BY REGION,
2019–2026 (USD MILLION) 115
TABLE 82 NORTH AMERICA: WESTERN BLOTTING MARKET FOR OTHER IMAGERS,
BY COUNTRY, 2019–2026 (USD MILLION) 115
TABLE 83 EUROPE: WESTERN BLOTTING MARKET FOR OTHER IMAGERS, BY COUNTRY, 2019–2026 (USD MILLION) 116
TABLE 84 APAC: WESTERN BLOTTING MARKET FOR OTHER IMAGERS, BY COUNTRY, 2019–2026 (USD MILLION) 116

7 WESTERN BLOTTING MARKET, BY APPLICATION 117
7.1 INTRODUCTION 118
TABLE 85 WESTERN BLOTTING MARKET, BY APPLICATION, 2019–2026 (USD MILLION) 118
7.2 BIOMEDICAL RESEARCH 118
7.2.1 INCREASING RESEARCH FUNDING FOR PROTEOMICS AND PROTEIN-BASED RESEARCH—A MAJOR DRIVER FOR THIS APPLICATION SEGMENT 118
TABLE 86 WESTERN BLOTTING MARKET FOR BIOMEDICAL RESEARCH APPLICATIONS, BY REGION, 2019–2026 (USD MILLION) 119
TABLE 87 NORTH AMERICA: WESTERN BLOTTING MARKET FOR BIOMEDICAL RESEARCH APPLICATIONS, BY COUNTRY, 2019–2026 (USD MILLION) 119
TABLE 88 EUROPE: WESTERN BLOTTING MARKET FOR BIOMEDICAL RESEARCH APPLICATIONS, BY COUNTRY, 2019–2026 (USD MILLION) 119
TABLE 89 APAC: WESTERN BLOTTING MARKET FOR BIOMEDICAL RESEARCH APPLICATIONS, BY COUNTRY, 2019–2026 (USD MILLION) 120
7.3 CLINICAL DIAGNOSTICS 120
TABLE 90 WESTERN BLOTTING MARKET FOR CLINICAL DIAGNOSTIC APPLICATIONS,
BY REGION, 2019–2026 (USD MILLION) 120
TABLE 91 NORTH AMERICA: WESTERN BLOTTING MARKET FOR CLINICAL DIAGNOSTIC APPLICATIONS, BY COUNTRY, 2019–2026 (USD MILLION) 121
TABLE 92 EUROPE: WESTERN BLOTTING MARKET FOR CLINICAL DIAGNOSTIC APPLICATIONS, BY COUNTRY, 2019–2026 (USD MILLION) 121
TABLE 93 APAC: WESTERN BLOTTING MARKET FOR CLINICAL DIAGNOSTIC APPLICATIONS, BY COUNTRY, 2019–2026 (USD MILLION) 121
TABLE 94 WESTERN BLOTTING MARKET FOR CLINICAL DIAGNOSTIC APPLICATIONS,
BY DISEASE TYPE, 2019–2026 (USD MILLION) 122
7.3.1 HIV 122
7.3.1.1 Western blotting is the most widely used method for HIV diagnosis—
a key factor driving market growth 122
TABLE 95 WESTERN BLOTTING MARKET FOR HIV DIAGNOSIS, BY REGION,
2019–2026 (USD MILLION) 122
TABLE 96 NORTH AMERICA: WESTERN BLOTTING MARKET FOR HIV DIAGNOSIS,
BY COUNTRY, 2019–2026 (USD MILLION) 123
TABLE 97 EUROPE: WESTERN BLOTTING MARKET FOR HIV DIAGNOSIS, BY COUNTRY, 2019–2026 (USD MILLION) 123
TABLE 98 APAC: WESTERN BLOTTING MARKET FOR HIV DIAGNOSIS, BY COUNTRY, 2019–2026 (USD MILLION) 123
7.3.2 HEPATITIS 124
7.3.2.1 Growing incidence of hepatitis C to drive market growth 124
TABLE 99 WESTERN BLOTTING MARKET FOR HEPATITIS DIAGNOSIS, BY REGION,
2019–2026 (USD MILLION) 124
TABLE 100 NORTH AMERICA: WESTERN BLOTTING MARKET FOR HEPATITIS DIAGNOSIS, BY COUNTRY, 2019–2026 (USD MILLION) 124
TABLE 101 EUROPE: WESTERN BLOTTING MARKET FOR HEPATITIS DIAGNOSIS,
BY COUNTRY, 2019–2026 (USD MILLION) 125
TABLE 102 APAC: WESTERN BLOTTING MARKET FOR HEPATITIS DIAGNOSIS,
BY COUNTRY, 2019–2026 (USD MILLION) 125

7.3.3 LYME DISEASE 125
7.3.3.1 Western blots are generally considered the most reliable tests currently available for Lyme disease diagnosis 125
TABLE 103 WESTERN BLOTTING MARKET FOR LYME DISEASE DIAGNOSIS, BY REGION, 2019–2026 (USD MILLION) 126
TABLE 104 NORTH AMERICA: WESTERN BLOTTING MARKET FOR LYME DISEASE DIAGNOSIS, BY COUNTRY, 2019–2026 (USD MILLION) 126
TABLE 105 EUROPE: WESTERN BLOTTING MARKET FOR LYME DISEASE DIAGNOSIS,
BY COUNTRY, 2019–2026 (USD MILLION) 126
TABLE 106 APAC: WESTERN BLOTTING MARKET FOR LYME DISEASE DIAGNOSIS,
BY COUNTRY, 2019–2026 (USD MILLION) 127
7.3.4 OTHER DISEASES 127
TABLE 107 WESTERN BLOTTING MARKET FOR OTHER DISEASES, BY REGION,
2019–2026 (USD MILLION) 127
TABLE 108 NORTH AMERICA: WESTERN BLOTTING MARKET FOR OTHER DISEASES,
BY COUNTRY, 2019–2026 (USD MILLION) 128
TABLE 109 EUROPE: WESTERN BLOTTING MARKET FOR OTHER DISEASES, BY COUNTRY, 2019–2026 (USD MILLION) 128
TABLE 110 APAC: WESTERN BLOTTING MARKET FOR OTHER DISEASES, BY COUNTRY, 2019–2026 (USD MILLION) 128
7.4 AGRICULTURAL APPLICATIONS 129
7.4.1 GROWING CULTIVATION OF GENETICALLY MODIFIED CROPS TO DRIVE MARKET GROWTH 129
TABLE 111 WESTERN BLOTTING MARKET FOR AGRICULTURAL APPLICATIONS,
BY REGION, 2019–2026 (USD MILLION) 129
TABLE 112 NORTH AMERICA: WESTERN BLOTTING MARKET FOR AGRICULTURAL APPLICATIONS, BY COUNTRY, 2019–2026 (USD MILLION) 129
TABLE 113 EUROPE: WESTERN BLOTTING MARKET FOR AGRICULTURAL APPLICATIONS, BY COUNTRY, 2019–2026 (USD MILLION) 130
TABLE 114 APAC: WESTERN BLOTTING MARKET FOR AGRICULTURAL APPLICATIONS,
BY COUNTRY, 2019–2026 (USD MILLION) 130
7.5 OTHER APPLICATIONS 130
TABLE 115 WESTERN BLOTTING MARKET FOR OTHER APPLICATIONS, BY REGION,
2019–2026 (USD MILLION) 131
TABLE 116 NORTH AMERICA: WESTERN BLOTTING MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2019–2026 (USD MILLION) 131
TABLE 117 EUROPE: WESTERN BLOTTING MARKET FOR OTHER APPLICATIONS,
BY COUNTRY, 2019–2026 (USD MILLION) 131
TABLE 118 APAC: WESTERN BLOTTING MARKET FOR OTHER APPLICATIONS,
BY COUNTRY, 2019–2026 (USD MILLION) 132
8 WESTERN BLOTTING MARKET, BY END USER 133
8.1 INTRODUCTION 134
TABLE 119 WESTERN BLOTTING MARKET, BY END USER, 2019–2026 (USD MILLION) 134
8.2 ACADEMIC & RESEARCH INSTITUTES 134
8.2.1 INCREASING GOVERNMENT INVESTMENTS FOR RESEARCH ACTIVITIES TO DRIVE GROWTH IN THIS MARKET SEGMENT 134
TABLE 120 WESTERN BLOTTING MARKET FOR ACADEMIC & RESEARCH INSTITUTES,
BY REGION, 2019–2026 (USD MILLION) 135
TABLE 121 NORTH AMERICA: WESTERN BLOTTING MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2019–2026 (USD MILLION) 135
TABLE 122 EUROPE: WESTERN BLOTTING MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2019–2026 (USD MILLION) 135
TABLE 123 APAC: WESTERN BLOTTING MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2019–2026 (USD MILLION) 136
8.3 BIOPHARMACEUTICAL & BIOTECHNOLOGY COMPANIES 136
8.3.1 GROWING DRUG DISCOVERY AND CLINICAL STUDIES TO DRIVE THE DEMAND FOR WESTERN BLOTTING IN THE PHARMA-BIOTECH INDUSTRY 136
TABLE 124 WESTERN BLOTTING MARKET FOR BIOPHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2019–2026 (USD MILLION) 137
TABLE 125 NORTH AMERICA: WESTERN BLOTTING MARKET FOR BIOPHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2019–2026 (USD MILLION) 137
TABLE 126 EUROPE: WESTERN BLOTTING MARKET FOR BIOPHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2019–2026 (USD MILLION) 137
TABLE 127 APAC: WESTERN BLOTTING MARKET FOR BIOPHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2019–2026 (USD MILLION) 138
8.4 HOSPITALS & DIAGNOSTIC LABORATORIES 138
8.4.1 GROWING PATIENT POPULATION AND TESTING VOLUMES TO DRIVE MARKET GROWTH 138
TABLE 128 WESTERN BLOTTING MARKET FOR HOSPITALS & DIAGNOSTIC LABORATORIES, BY REGION, 2019–2026 (USD MILLION) 139
TABLE 129 NORTH AMERICA: WESTERN BLOTTING MARKET FOR HOSPITALS & DIAGNOSTIC LABORATORIES, BY COUNTRY, 2019–2026 (USD MILLION) 139
TABLE 130 EUROPE: WESTERN BLOTTING MARKET FOR HOSPITALS & DIAGNOSTIC LABORATORIES, BY COUNTRY, 2019–2026 (USD MILLION) 140
TABLE 131 APAC: WESTERN BLOTTING FOR HOSPITALS & DIAGNOSTIC LABORATORIES, BY COUNTRY, 2019–2026 (USD MILLION) 140
8.5 OTHER END USERS 140
TABLE 132 WESTERN BLOTTING MARKET FOR OTHER END USERS, BY REGION,
2019–2026 (USD MILLION) 141
TABLE 133 NORTH AMERICA: WESTERN BLOTTING MARKET FOR OTHER END USERS,
BY COUNTRY, 2019–2026 (USD MILLION) 141
TABLE 134 EUROPE: WESTERN BLOTTING MARKET FOR OTHER END USERS,
BY COUNTRY, 2019–2026 (USD MILLION) 141
TABLE 135 APAC: WESTERN BLOTTING MARKET FOR OTHER END USERS, BY COUNTRY, 2019–2026 (USD MILLION) 142
9 WESTERN BLOTTING MARKET, BY REGION 143
9.1 INTRODUCTION 144
9.2 NORTH AMERICA 144
FIGURE 25 NORTH AMERICA: WESTERN BLOTTING MARKET SNAPSHOT 144
TABLE 136 NORTH AMERICA: WESTERN BLOTTING MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 145
TABLE 137 NORTH AMERICA: WESTERN BLOTTING MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 145
TABLE 138 NORTH AMERICA: WESTERN BLOTTING INSTRUMENTS MARKET, BY TYPE, 2019–2026 (USD MILLION) 145
TABLE 139 NORTH AMERICA: WESTERN BLOTTING INSTRUMENTS MARKET FOR BLOTTING SYSTEMS, BY TYPE, 2019–2026 (USD MILLION) 145
TABLE 140 NORTH AMERICA: WESTERN BLOTTING INSTRUMENTS MARKET FOR IMAGERS, BY TYPE, 2019–2026 (USD MILLION) 146
TABLE 141 NORTH AMERICA: WESTERN BLOTTING CONSUMABLES MARKET, BY TYPE, 2019–2026 (USD MILLION) 146
TABLE 142 NORTH AMERICA: WESTERN BLOTTING CONSUMABLES MARKET FOR ANTIBODIES & CONJUGATES, BY TYPE, 2019–2026 (USD MILLION) 146
TABLE 143 NORTH AMERICA: WESTERN BLOTTING MARKET, BY APPLICATION,
2019–2026 (USD MILLION) 147
TABLE 144 NORTH AMERICA: WESTERN BLOTTING MARKET FOR CLINICAL DIAGNOSTIC APPLICATIONS, BY DISEASE TYPE, 2019–2026 (USD MILLION) 147
TABLE 145 NORTH AMERICA: WESTERN BLOTTING MARKET, BY END USER,
2019–2026 (USD MILLION) 147
9.2.1 US 148
9.2.1.1 The US dominates the North American western blotting market 148
TABLE 146 US: WESTERN BLOTTING MARKET, BY PRODUCT, 2019–2026 (USD MILLION) 148
TABLE 147 US: WESTERN BLOTTING INSTRUMENTS MARKET, BY TYPE,
2019–2026 (USD MILLION) 148
TABLE 148 US: WESTERN BLOTTING INSTRUMENTS MARKET FOR BLOTTING SYSTEMS, BY TYPE, 2019–2026 (USD MILLION) 149
TABLE 149 US: WESTERN BLOTTING INSTRUMENTS MARKET FOR IMAGERS, BY TYPE, 2019–2026 (USD MILLION) 149
TABLE 150 US: WESTERN BLOTTING CONSUMABLES MARKET, BY TYPE,
2019–2026 (USD MILLION) 149
TABLE 151 US: WESTERN BLOTTING CONSUMABLES MARKET FOR ANTIBODIES & CONJUGATES, BY TYPE, 2019–2026 (USD MILLION) 150
TABLE 152 US: WESTERN BLOTTING MARKET, BY APPLICATION,
2019–2026 (USD MILLION) 150
TABLE 153 US: WESTERN BLOTTING MARKET FOR CLINICAL DIAGNOSTIC APPLICATIONS, BY DISEASE TYPE, 2019–2026 (USD MILLION) 150
TABLE 154 US: WESTERN BLOTTING MARKET, BY END USER, 2019–2026 (USD MILLION) 151
9.2.2 CANADA 151
9.2.2.1 Strong infrastructure and availability of funding for biomedical research to support market growth in Canada 151
TABLE 155 CANADA: WESTERN BLOTTING MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 152
TABLE 156 CANADA: WESTERN BLOTTING INSTRUMENTS MARKET, BY TYPE,
2019–2026 (USD MILLION) 152
TABLE 157 CANADA: WESTERN BLOTTING INSTRUMENTS MARKET FOR BLOTTING SYSTEMS, BY TYPE, 2019–2026 (USD MILLION) 152
TABLE 158 CANADA: WESTERN BLOTTING INSTRUMENTS MARKET FOR IMAGERS,
BY TYPE, 2019–2026 (USD MILLION) 152
TABLE 159 CANADA: WESTERN BLOTTING CONSUMABLES MARKET, BY TYPE,
2019–2026 (USD MILLION) 153
TABLE 160 CANADA: WESTERN BLOTTING CONSUMABLES MARKET FOR ANTIBODIES & CONJUGATES, BY TYPE, 2019–2026 (USD MILLION) 153
TABLE 161 CANADA: WESTERN BLOTTING MARKET, BY APPLICATION,
2019–2026 (USD MILLION) 153
TABLE 162 CANADA: WESTERN BLOTTING MARKET FOR CLINICAL DIAGNOSTIC APPLICATIONS, BY DISEASE TYPE, 2019–2026 (USD MILLION) 154
TABLE 163 CANADA: WESTERN BLOTTING MARKET, BY END USER,
2019–2026 (USD MILLION) 154
9.3 EUROPE 154
TABLE 164 EUROPE: WESTERN BLOTTING MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 155
TABLE 165 EUROPE: WESTERN BLOTTING MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 155
TABLE 166 EUROPE: WESTERN BLOTTING INSTRUMENTS MARKET, BY TYPE,
2019–2026 (USD MILLION) 155
TABLE 167 EUROPE: WESTERN BLOTTING INSTRUMENTS MARKET FOR BLOTTING SYSTEMS, BY TYPE, 2019–2026 (USD MILLION) 156
TABLE 168 EUROPE: WESTERN BLOTTING INSTRUMENTS MARKET FOR IMAGERS,
BY TYPE, 2019–2026 (USD MILLION) 156
TABLE 169 EUROPE: WESTERN BLOTTING CONSUMABLES MARKET, BY TYPE,
2019–2026 (USD MILLION) 156
TABLE 170 EUROPE: WESTERN BLOTTING CONSUMABLES MARKET FOR ANTIBODIES & CONJUGATES, BY TYPE, 2019–2026 (USD MILLION) 157
TABLE 171 EUROPE: WESTERN BLOTTING MARKET, BY APPLICATION,
2019–2026 (USD MILLION) 157
TABLE 172 EUROPE: WESTERN BLOTTING MARKET FOR CLINICAL DIAGNOSTIC APPLICATIONS, BY DISEASE TYPE, 2019–2026 (USD MILLION) 157
TABLE 173 EUROPE: WESTERN BLOTTING MARKET, BY END USER,
2019–2026 (USD MILLION) 158
9.3.1 GERMANY 158
9.3.1.1 Germany is the largest market for western blotting in Europe 158
TABLE 174 GERMANY: WESTERN BLOTTING MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 159
TABLE 175 GERMANY: WESTERN BLOTTING INSTRUMENTS MARKET, BY TYPE,
2019–2026 (USD MILLION) 159
TABLE 176 GERMANY: WESTERN BLOTTING INSTRUMENTS MARKET FOR BLOTTING SYSTEMS, BY TYPE, 2019–2026 (USD MILLION) 159
TABLE 177 GERMANY: WESTERN BLOTTING INSTRUMENTS MARKET FOR IMAGERS MARKET, BY TYPE, 2019–2026 (USD MILLION) 160
TABLE 178 GERMANY: WESTERN BLOTTING CONSUMABLES MARKET, BY TYPE,
2019–2026 (USD MILLION) 160
TABLE 179 GERMANY: WESTERN BLOTTING CONSUMABLES MARKET FOR ANTIBODIES & CONJUGATES, BY TYPE, 2019–2026 (USD MILLION) 160
TABLE 180 GERMANY: WESTERN BLOTTING MARKET, BY APPLICATION,
2019–2026 (USD MILLION) 161
TABLE 181 GERMANY: WESTERN BLOTTING MARKET FOR CLINICAL DIAGNOSTIC APPLICATIONS, BY DISEASE TYPE, 2019–2026 (USD MILLION) 161
TABLE 182 GERMANY: WESTERN BLOTTING MARKET, BY END USER,
2019–2026 (USD MILLION) 161

9.3.2 FRANCE 162
9.3.2.1 Proteomics research in France is strongly supported
by the government—a key factor driving market growth 162
TABLE 183 FRANCE: WESTERN BLOTTING MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 162
TABLE 184 FRANCE: WESTERN BLOTTING INSTRUMENTS MARKET, BY TYPE,
2019–2026 (USD MILLION) 163
TABLE 185 FRANCE: WESTERN BLOTTING INSTRUMENTS MARKET FOR BLOTTING SYSTEMS, BY TYPE, 2019–2026 (USD MILLION) 163
TABLE 186 FRANCE: WESTERN BLOTTING INSTRUMENTS MARKET FOR IMAGERS,
BY TYPE, 2019–2026 (USD MILLION) 163
TABLE 187 FRANCE: WESTERN BLOTTING CONSUMABLES MARKET, BY TYPE,
2019–2026 (USD MILLION) 164
TABLE 188 FRANCE: WESTERN BLOTTING CONSUMABLES MARKET FOR ANTIBODIES & CONJUGATES, BY TYPE, 2019–2026 (USD MILLION) 164
TABLE 189 FRANCE: WESTERN BLOTTING MARKET, BY APPLICATION,
2019–2026 (USD MILLION) 164
TABLE 190 FRANCE: WESTERN BLOTTING MARKET FOR CLINICAL DIAGNOSTIC APPLICATIONS, BY DISEASE TYPE, 2019–2026 (USD MILLION) 165
TABLE 191 FRANCE: WESTERN BLOTTING MARKET, BY END USER,
2019–2026 (USD MILLION) 165
9.3.3 UK 165
9.3.3.1 Government support for disease diagnostics and the favorable investment scenario to drive the market in the UK 165
TABLE 192 UK: WESTERN BLOTTING MARKET, BY PRODUCT, 2019–2026 (USD MILLION) 166
TABLE 193 UK: WESTERN BLOTTING INSTRUMENTS MARKET, BY TYPE,
2019–2026 (USD MILLION) 166
TABLE 194 UK: WESTERN BLOTTING INSTRUMENTS MARKET FOR BLOTTING SYSTEMS, BY TYPE, 2019–2026 (USD MILLION) 167
TABLE 195 UK: WESTERN BLOTTING INSTRUMENTS MARKET FOR IMAGERS, BY TYPE, 2019–2026 (USD MILLION) 167
TABLE 196 UK: WESTERN BLOTTING CONSUMABLES MARKET, BY TYPE,
2019–2026 (USD MILLION) 167
TABLE 197 UK: WESTERN BLOTTING CONSUMABLES MARKET FOR ANTIBODIES & CONJUGATES, BY TYPE, 2019–2026 (USD MILLION) 168
TABLE 198 UK: WESTERN BLOTTING MARKET, BY APPLICATION,
2019–2026 (USD MILLION) 168
TABLE 199 UK: WESTERN BLOTTING MARKET FOR CLINICAL DIAGNOSTIC APPLICATIONS, BY DISEASE TYPE, 2019–2026 (USD MILLION) 168
TABLE 200 UK: WESTERN BLOTTING MARKET, BY END USER, 2019–2026 (USD MILLION) 169
9.3.4 ITALY 169
9.3.4.1 Growth in this market is mainly driven by increasing life science R&D in the country 169
TABLE 201 ITALY: WESTERN BLOTTING MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 170
TABLE 202 ITALY: WESTERN BLOTTING INSTRUMENTS MARKET, BY TYPE,
2019–2026 (USD MILLION) 170
TABLE 203 ITALY: WESTERN BLOTTING INSTRUMENTS MARKET FOR BLOTTING SYSTEMS, BY TYPE, 2019–2026 (USD MILLION) 170
TABLE 204 ITALY: WESTERN BLOTTING INSTRUMENTS MARKET FOR IMAGERS, BY TYPE, 2019–2026 (USD MILLION) 171
TABLE 205 ITALY: WESTERN BLOTTING CONSUMABLES MARKET, BY TYPE,
2019–2026 (USD MILLION) 171
TABLE 206 ITALY: WESTERN BLOTTING CONSUMABLES MARKET FOR ANTIBODIES & CONJUGATES, BY TYPE, 2019–2026 (USD MILLION) 171
TABLE 207 ITALY: WESTERN BLOTTING MARKET, BY APPLICATION,
2019–2026 (USD MILLION) 172
TABLE 208 ITALY: WESTERN BLOTTING MARKET FOR CLINICAL DIAGNOSTIC APPLICATIONS, BY DISEASE TYPE, 2019–2026 (USD MILLION) 172
TABLE 209 ITALY: WESTERN BLOTTING MARKET, BY END USER,
2019–2026 (USD MILLION) 172
9.3.5 SPAIN 173
9.3.5.1 Well-established network for translational medicine research to drive market growth in Spain 173
TABLE 210 SPAIN: WESTERN BLOTTING MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 173
TABLE 211 SPAIN: WESTERN BLOTTING INSTRUMENTS MARKET, BY TYPE,
2019–2026 (USD MILLION) 174
TABLE 212 SPAIN: WESTERN BLOTTING INSTRUMENTS MARKET FOR BLOTTING SYSTEMS, BY TYPE, 2019–2026 (USD MILLION) 174
TABLE 213 SPAIN: WESTERN BLOTTING INSTRUMENTS MARKET FOR IMAGERS, BY TYPE, 2019–2026 (USD MILLION) 174
TABLE 214 SPAIN: WESTERN BLOTTING CONSUMABLES MARKET, BY TYPE,
2019–2026 (USD MILLION) 175
TABLE 215 SPAIN: WESTERN BLOTTING CONSUMABLES MARKET FOR ANTIBODIES & CONJUGATES, BY TYPE, 2019–2026 (USD MILLION) 175
TABLE 216 SPAIN: WESTERN BLOTTING MARKET, BY APPLICATION,
2019–2026 (USD MILLION) 175
TABLE 217 SPAIN: WESTERN BLOTTING MARKET FOR CLINICAL DIAGNOSTIC APPLICATIONS, BY DISEASE TYPE, 2019–2026 (USD MILLION) 176
TABLE 218 SPAIN: WESTERN BLOTTING MARKET, BY END USER,
2019–2026 (USD MILLION) 176
9.3.6 REST OF EUROPE (ROE) 176
TABLE 219 ROE: WESTERN BLOTTING MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 177
TABLE 220 ROE: WESTERN BLOTTING INSTRUMENTS MARKET, BY TYPE,
2019–2026 (USD MILLION) 177
TABLE 221 ROE: WESTERN BLOTTING INSTRUMENTS MARKET FOR BLOTTING SYSTEMS, BY TYPE, 2019–2026 (USD MILLION) 178
TABLE 222 ROE: WESTERN BLOTTING INSTRUMENTS MARKET FOR IMAGERS, BY TYPE, 2019–2026 (USD MILLION) 178
TABLE 223 ROE: WESTERN BLOTTING CONSUMABLES MARKET, BY TYPE,
2019–2026 (USD MILLION) 178
TABLE 224 ROE: WESTERN BLOTTING CONSUMABLES MARKET FOR ANTIBODIES & CONJUGATES, BY TYPE, 2019–2026 (USD MILLION) 179
TABLE 225 ROE: WESTERN BLOTTING MARKET, BY APPLICATION,
2019–2026 (USD MILLION) 179
TABLE 226 ROE: WESTERN BLOTTING MARKET FOR CLINICAL DIAGNOSTIC APPLICATIONS, BY DISEASE TYPE, 2019–2026 (USD MILLION) 179
TABLE 227 ROE: WESTERN BLOTTING MARKET, BY END USER,
2019–2026 (USD MILLION) 180
9.4 ASIA PACIFIC 181
FIGURE 26 ASIA PACIFIC: WESTERN BLOTTING MARKET SNAPSHOT 181
TABLE 228 APAC: WESTERN BLOTTING MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 182
TABLE 229 APAC: WESTERN BLOTTING MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 182
TABLE 230 APAC: WESTERN BLOTTING INSTRUMENTS MARKET, BY TYPE,
2019–2026 (USD MILLION) 182
TABLE 231 APAC: WESTERN BLOTTING INSTRUMENTS MARKET FOR BLOTTING SYSTEMS, BY TYPE, 2019–2026 (USD MILLION) 183
TABLE 232 APAC: WESTERN BLOTTING INSTRUMENTS MARKET FOR IMAGERS, BY TYPE, 2019–2026 (USD MILLION) 183
TABLE 233 APAC: WESTERN BLOTTING CONSUMABLES MARKET, BY TYPE,
2019–2026 (USD MILLION) 183
TABLE 234 APAC: WESTERN BLOTTING CONSUMABLES MARKET FOR ANTIBODIES & CONJUGATES, BY TYPE, 2019–2026 (USD MILLION) 184
TABLE 235 APAC: WESTERN BLOTTING MARKET, BY APPLICATION,
2019–2026 (USD MILLION) 184
TABLE 236 APAC: WESTERN BLOTTING MARKET FOR CLINICAL DIAGNOSTIC APPLICATIONS, BY DISEASE TYPE, 2019–2026 (USD MILLION) 184
TABLE 237 APAC: WESTERN BLOTTING MARKET, BY END USER,
2019–2026 (USD MILLION) 185
9.4.1 JAPAN 185
9.4.1.1 Growing research initiatives towards the development of precision medicine are supporting market growth in Japan 185
TABLE 238 JAPAN: WESTERN BLOTTING MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 186
TABLE 239 JAPAN: WESTERN BLOTTING INSTRUMENTS MARKET, BY TYPE,
2019–2026 (USD MILLION) 186
TABLE 240 JAPAN: WESTERN BLOTTING INSTRUMENTS MARKET FOR BLOTTING SYSTEMS, BY TYPE, 2019–2026 (USD MILLION) 186
TABLE 241 JAPAN: WESTERN BLOTTING INSTRUMENTS MARKET FOR IMAGERS, BY TYPE, 2019–2026 (USD MILLION) 186
TABLE 242 JAPAN: WESTERN BLOTTING CONSUMABLES MARKET, BY TYPE,
2019–2026 (USD MILLION) 187
TABLE 243 JAPAN: WESTERN BLOTTING CONSUMABLES MARKET FOR ANTIBODIES & CONJUGATES, BY TYPE, 2019–2026 (USD MILLION) 187
TABLE 244 JAPAN: WESTERN BLOTTING MARKET, BY APPLICATION,
2019–2026 (USD MILLION) 187
TABLE 245 JAPAN: WESTERN BLOTTING MARKET FOR CLINICAL DIAGNOSTIC APPLICATIONS, BY DISEASE TYPE, 2019–2026 (USD MILLION) 188
TABLE 246 JAPAN: WESTERN BLOTTING MARKET, BY END USER,
2019–2026 (USD MILLION) 188

9.4.2 CHINA 188
9.4.2.1 Increasing government support for the biomedical and biotechnology industries to drive market growth 188
TABLE 247 CHINA: WESTERN BLOTTING MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 189
TABLE 248 CHINA: WESTERN BLOTTING INSTRUMENTS MARKET, BY TYPE,
2019–2026 (USD MILLION) 189
TABLE 249 CHINA: WESTERN BLOTTING INSTRUMENTS MARKET FOR BLOTTING SYSTEMS, BY TYPE, 2019–2026 (USD MILLION) 189
TABLE 250 CHINA: WESTERN BLOTTING INSTRUMENTS MARKET FOR IMAGERS, BY TYPE, 2019–2026 (USD MILLION) 190
TABLE 251 CHINA: WESTERN BLOTTING CONSUMABLES MARKET, BY TYPE,
2019–2026 (USD MILLION) 190
TABLE 252 CHINA: WESTERN BLOTTING CONSUMABLES MARKET FOR ANTIBODIES & CONJUGATES, BY TYPE, 2019–2026 (USD MILLION) 190
TABLE 253 CHINA: WESTERN BLOTTING MARKET, BY APPLICATION,
2019–2026 (USD MILLION) 191
TABLE 254 CHINA: WESTERN BLOTTING MARKET FOR CLINICAL DIAGNOSTIC APPLICATIONS, BY DISEASE TYPE, 2019–2026 (USD MILLION) 191
TABLE 255 CHINA: WESTERN BLOTTING MARKET, BY END USER,
2019–2026 (USD MILLION) 191
9.4.3 INDIA 192
9.4.3.1 Growing pharmaceutical & biotechnology industry in India, backed by government initiatives, to drive market growth 192
TABLE 256 INDIA: WESTERN BLOTTING MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 193
TABLE 257 INDIA: WESTERN BLOTTING INSTRUMENTS MARKET, BY TYPE,
2019–2026 (USD MILLION) 193
TABLE 258 INDIA: WESTERN BLOTTING INSTRUMENTS MARKET FOR BLOTTING SYSTEMS, BY TYPE, 2019–2026 (USD MILLION) 193
TABLE 259 INDIA: WESTERN BLOTTING INSTRUMENTS MARKET FOR IMAGERS, BY TYPE, 2019–2026 (USD MILLION) 193
TABLE 260 INDIA: WESTERN BLOTTING CONSUMABLES MARKET, BY TYPE,
2019–2026 (USD MILLION) 194
TABLE 261 INDIA: WESTERN BLOTTING CONSUMABLES MARKET FOR ANTIBODIES & CONJUGATES, BY TYPE, 2019–2026 (USD MILLION) 194
TABLE 262 INDIA: WESTERN BLOTTING MARKET, BY APPLICATION,
2019–2026 (USD MILLION) 194
TABLE 263 INDIA: WESTERN BLOTTING MARKET FOR CLINICAL DIAGNOSTIC APPLICATIONS, BY DISEASE TYPE, 2019–2026 (USD MILLION) 195
TABLE 264 INDIA: WESTERN BLOTTING MARKET, BY END USER,
2019–2026 (USD MILLION) 195
9.4.4 ROAPAC 195
TABLE 265 ROAPAC: WESTERN BLOTTING MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 196
TABLE 266 ROAPAC: WESTERN BLOTTING INSTRUMENTS MARKET, BY TYPE,
2019–2026 (USD MILLION) 196
TABLE 267 ROAPAC: WESTERN BLOTTING INSTRUMENTS MARKET FOR BLOTTING SYSTEMS, BY TYPE, 2019–2026 (USD MILLION) 196
TABLE 268 ROAPAC: WESTERN BLOTTING INSTRUMENTS MARKET FOR IMAGERS,
BY TYPE, 2019–2026 (USD MILLION) 196
TABLE 269 ROAPAC: WESTERN BLOTTING CONSUMABLES MARKET, BY TYPE,
2019–2026 (USD MILLION) 197
TABLE 270 ROAPAC: WESTERN BLOTTING CONSUMABLES MARKET FOR ANTIBODIES & CONJUGATES, BY TYPE, 2019–2026 (USD MILLION) 197
TABLE 271 ROAPAC: WESTERN BLOTTING MARKET, BY APPLICATION,
2019–2026 (USD MILLION) 197
TABLE 272 ROAPAC: WESTERN BLOTTING MARKET FOR CLINICAL DIAGNOSTIC APPLICATIONS, BY DISEASE TYPE, 2019–2026 (USD MILLION) 198
TABLE 273 ROAPAC: WESTERN BLOTTING MARKET, BY END USER,
2019–2026 (USD MILLION) 198
9.5 LATIN AMERICA 198
9.5.1 INCREASING ADOPTION OF PROTEOMICS TECHNOLOGIES IN THE REGION TO DRIVE MARKET GROWTH 198
TABLE 274 LATAM: WESTERN BLOTTING MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 199
TABLE 275 LATAM: WESTERN BLOTTING INSTRUMENTS MARKET, BY TYPE,
2019–2026 (USD MILLION) 199
TABLE 276 LATAM: WESTERN BLOTTING INSTRUMENTS MARKET FOR BLOTTING SYSTEMS, BY TYPE, 2019–2026 (USD MILLION) 199
TABLE 277 LATAM: WESTERN BLOTTING INSTRUMENTS MARKET FOR IMAGERS, BY TYPE, 2019–2026 (USD MILLION) 200
TABLE 278 LATAM: WESTERN BLOTTING CONSUMABLES MARKET, BY TYPE,
2019–2026 (USD MILLION) 200
TABLE 279 LATAM: WESTERN BLOTTING CONSUMABLES MARKET FOR ANTIBODIES & CONJUGATES, BY TYPE, 2019–2026 (USD MILLION) 200
TABLE 280 LATAM: WESTERN BLOTTING MARKET, BY APPLICATION,
2019–2026 (USD MILLION) 201
TABLE 281 LATAM: WESTERN BLOTTING MARKET FOR CLINICAL DIAGNOSTIC APPLICATIONS, BY DISEASE TYPE, 2019–2026 (USD MILLION) 201
TABLE 282 LATAM: WESTERN BLOTTING MARKET, BY END USER,
2019–2026 (USD MILLION) 201
9.6 MIDDLE EAST & AFRICA 202
9.6.1 PRESENCE OF A LARGER PATIENT POPULATION TO DRIVE THE MARKET IN THIS REGION 202
TABLE 283 MEA: WESTERN BLOTTING MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 202
TABLE 284 MEA: WESTERN BLOTTING INSTRUMENTS MARKET, BY TYPE,
2019–2026 (USD MILLION) 202
TABLE 285 MEA: WESTERN BLOTTING INSTRUMENTS MARKET FOR BLOTTING SYSTEMS, BY TYPE, 2019–2026 (USD MILLION) 203
TABLE 286 MEA: WESTERN BLOTTING INSTRUMENTS MARKET FOR IMAGERS, BY TYPE, 2019–2026 (USD MILLION) 203
TABLE 287 MEA: WESTERN BLOTTING CONSUMABLES MARKET, BY TYPE,
2019–2026 (USD MILLION) 203
TABLE 288 MEA: WESTERN BLOTTING CONSUMABLES MARKET FOR ANTIBODIES & CONJUGATES, BY TYPE, 2019–2026 (USD MILLION) 204
TABLE 289 MEA: WESTERN BLOTTING MARKET, BY APPLICATION,
2019–2026 (USD MILLION) 204
TABLE 290 MEA: WESTERN BLOTTING MARKET FOR CLINICAL DIAGNOSTIC APPLICATIONS, BY DISEASE TYPE, 2019–2026 (USD MILLION) 204
TABLE 291 MEA: WESTERN BLOTTING MARKET, BY END USER,
2019–2026 (USD MILLION) 205
10 COMPETITIVE LANDSCAPE 206
10.1 KEY PLAYER STRATEGIES 206
10.2 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN THE WESTERN BLOTTING MARKET 207
10.3 MARKET SHARE ANALYSIS 208
FIGURE 27 WESTERN BLOTTING MARKET: MARKET SHARE ANALYSIS OF KEY PLAYERS, 2020 208
TABLE 292 WESTERN BLOTTING MARKET: DEGREE OF COMPETITION 208
10.4 REVENUE ANALYSIS 210
FIGURE 28 REVENUE ANALYSIS FOR KEY COMPANIES (2017–2020) 210
10.5 COMPANY EVALUATION QUADRANT 211
FIGURE 29 WESTERN BLOTTING MARKET (GLOBAL) COMPANY EVALUATION MATRIX, 2020 211
10.5.1 STARS 212
10.5.2 PERVASIVE PLAYERS 212
10.5.3 EMERGING LEADERS 212
10.5.4 PARTICIPANTS 212
10.6 COMPETITIVE LEADERSHIP MAPPING (START-UPS) (2020) 213
10.6.1 PROGRESSIVE COMPANIES 213
10.6.2 STARTING BLOCKS 213
10.6.3 DYNAMIC COMPANIES 213
10.6.4 RESPONSIVE COMPANIES 213
FIGURE 30 COMPETITIVE LEADERSHIP MAPPING: WESTERN BLOTTING MARKET 214
10.7 COMPETITIVE BENCHMARKING 215
TABLE 293 COMPANY PRODUCT FOOTPRINT (25 COMPANIES) 215
TABLE 294 COMPANY REGIONAL FOOTPRINT (25 COMPANIES) 216
10.8 COMPETITIVE SCENARIO 217
10.8.1 PRODUCT LAUNCHES 217
TABLE 295 WESTERN BLOTTING MARKET: PRODUCT LAUNCHES,
JANUARY 2018–OCTOBER 2021 217
10.8.2 DEALS 218
TABLE 296 WESTERN BLOTTING MARKET: DEALS, JANUARY 2018–OCTOBER 2021 218
10.8.3 OTHER DEVELOPMENTS 219
TABLE 297 WESTERN BLOTTING MARKET: OTHER DEVELOPMENTS,
JANUARY 2018–OCTOBER 2021 219

11 COMPANY PROFILES 220
11.1 KEY COMPANIES 220
(Business Overview, Products/Services/Solutions Offered, MnM View, Key Strengths and Right to Win, Strategic Choices Made, Weaknesses and Competitive Threats, Recent Developments)*
11.1.1 BIO-RAD LABORATORIES, INC. 220
TABLE 298 BIO-RAD LABORATORIES, INC.: BUSINESS OVERVIEW 220
FIGURE 31 COMPANY SNAPSHOT: BIO-RAD LABORATORIES, INC. (2020) 221
11.1.2 THERMO FISHER SCIENTIFIC INC. 224
TABLE 299 THERMO FISHER SCIENTIFIC INC.: BUSINESS OVERVIEW 224
FIGURE 32 COMPANY SNAPSHOT: THERMO FISHER SCIENTIFIC INC. (2020) 225
11.1.3 DANAHER CORPORATION 228
TABLE 300 DANAHER CORPORATION: BUSINESS OVERVIEW 228
FIGURE 33 COMPANY SNAPSHOT: DANAHER CORPORATION (2020) 229
11.1.4 BIO-TECHNE CORPORATION 232
TABLE 301 BIO-TECHNE CORPORATION: BUSINESS OVERVIEW 232
FIGURE 34 BIO-TECHNE CORPORATION: COMPANY SNAPSHOT (2021) 233
11.1.5 MERCK KGAA 236
TABLE 302 MERCK KGAA: BUSINESS OVERVIEW 236
FIGURE 35 COMPANY SNAPSHOT: MERCK KGAA (2020) 237
11.1.6 PERKINELMER, INC. 239
TABLE 303 PERKINELMER, INC.: BUSINESS OVERVIEW 239
FIGURE 36 PERKINELMER, INC.: COMPANY SNAPSHOT (2020) 240
11.1.7 ABCAM PLC 242
TABLE 304 ABCAM PLC: BUSINESS OVERVIEW 242
FIGURE 37 COMPANY SNAPSHOT: ABCAM PLC (2020) 243
11.1.8 ENZO BIOCHEM, INC. 246
TABLE 305 ENZO BIOCHEM, INC.: BUSINESS OVERVIEW 246
FIGURE 38 COMPANY SNAPSHOT: ENZO BIOCHEM, INC. (2020) 247
11.1.9 LI-COR, INC. 249
TABLE 306 LI-COR, INC.: BUSINESS OVERVIEW 249
11.1.10 ADVANSTA INC. 251
TABLE 307 ADVANSTA INC.: BUSINESS OVERVIEW 251
11.1.11 CELL SIGNALING TECHNOLOGY, INC. 253
TABLE 308 CELL SIGNALING TECHNOLOGY, INC.: BUSINESS OVERVIEW 253
11.1.12 AZURE BIOSYSTEMS, INC. 254
TABLE 309 AZURE BIOSYSTEMS, INC.: BUSINESS OVERVIEW 254
11.1.13 BOSTER BIOLOGICAL TECHNOLOGY 256
TABLE 310 BOSTER BIOLOGICAL TECHNOLOGY: BUSINESS OVERVIEW 256
11.1.14 GENO TECHNOLOGY INC. 258
TABLE 311 GENO TECHNOLOGY INC.: BUSINESS OVERVIEW 258
11.1.15 STRESSMARQ BIOSCIENCES INC. 260
TABLE 312 STRESSMARQ BIOSCIENCES INC.: BUSINESS OVERVIEW 260
*Business Overview, Products/Services/Solutions Offered, MnM View, Key Strengths and Right to Win, Strategic Choices Made, Weaknesses and Competitive Threats, Recent Developments might not be captured in case of unlisted companies.
11.2 OTHER COMPANIES 261
11.2.1 F. HOFFMANN-LA ROCHE LTD. 261
11.2.2 ROCKLAND IMMUNOCHEMICALS, INC. 262
11.2.3 PRECISION BIOSYSTEMS 263
11.2.4 CLEAVER SCIENTIFIC LTD. 263
11.2.5 PROTEINTECH GROUP 264
11.2.6 ABNOVA CORPORATION 264
11.2.7 SINO BIOLOGICAL INC. 265
11.2.8 ABBEXA LTD. 265
11.2.9 COVALAB S.A.S. 266
11.2.10 BIORBYT LTD. 266
12 APPENDIX 267
12.1 DISCUSSION GUIDE 267
12.2 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 272
12.3 AVAILABLE CUSTOMIZATIONS 274
12.4 RELATED REPORTS 274
12.5 AUTHOR DETAILS 275


お問合せフォーム

    ※レポートのタイトルは自動で入ります。

    お名前(必須)

    会社名(必須)

    部署名

    メールアドレス(必須)

    電話番号

    当ウェブサイトを知った経由を教えてください。

    お問合せ区分(必須)

    お問合せ内容(必須)

    株式会社SEMABIZ・ChosaReport.com プライバシーポリシー

    Eメールでのお問合せもお受けしております。
    下記アドレスへ“(at)”を“@”に変えてお送りください。通常1営業日以内にご返信いたします。
    crinquiry(at)chosareport.com